CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
54.92
+0.94 (1.74%)
At close: Jun 26, 2026, 4:00 PM EDT
54.86
-0.06 (-0.11%)
After-hours: Jun 26, 2026, 7:59 PM EDT
CRISPR Therapeutics AG Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for CRISPR Therapeutics AG stock have an average target of 73.8, with a low estimate of 45 and a high estimate of 110. The average target predicts an increase of 34.38% from the current stock price of 54.92.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRISPR Therapeutics AG stock from 25 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 13 | 11 | 11 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 9 | 9 | 9 | 9 | 9 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 27 | 27 | 27 | 27 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Upgrades $60 | Hold | Upgrades | $60 | +9.25% | Jun 11, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $85 | Buy | Maintains | $85 | +54.77% | Jun 10, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $83 | Buy | Maintains | $83 | +51.13% | May 14, 2026 |
| Bernstein | Bernstein | Hold Reiterates $50 → $56 | Hold | Reiterates | $50 → $56 | +1.97% | May 13, 2026 |
Financial Forecast
Revenue This Year
36.32M
from 3.51M
Increased by 934.65%
Revenue Next Year
145.08M
from 36.32M
Increased by 299.50%
EPS This Year
-4.82
from -6.47
EPS Next Year
-3.83
from -4.82
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 251.2M | 509.0M | |
| Avg | 36.3M | 145.1M | |
| Low | n/a | 1.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7,057.4% | 1,301.6% | |
| Avg | 934.6% | 299.5% | |
| Low | -100.0% | -95.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.35 | -0.68 | |
| Avg | -4.82 | -3.83 | |
| Low | -6.37 | -6.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.